Artal Group’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,318
Closed -$124K 134
2023
Q1
$124K Buy
+4,318
New +$124K 0.01% 114